Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 151 - 160 of 394

Selected Filters:
20 February 2023

High PrEP Uptake and Objective Longitudinal Adherence among HIV-exposed Women with Personal or Partner Plans for Pregnancy in Rural Uganda: A cohort study

This article from PLOS Medicine describes the impact of the Healthy Families-PrEP intervention to support PrEP use as part of HIV prevention during periconception and pregnancy periods in Uganda.

Research, Service Delivery

External Link
20 February 2023

Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria

This article from Global Health: Science and Practice describes the impact of the Meeting Targets and Maintaining Epidemic Control (EpiC) project’s comprehensive community-based program to increase access to and uptake of oral PrEP services among people who inject drugs in Bayelsa and Niger States, Nigeria.

Research, Service Delivery

External Link
17 February 2023

New PrEP Product Implementation Roadmap for PrEP vaginal ring and CAB for PrEP in Uganda

This presentation outlines the timelines for implementation of the dapivirine vaginal ring and cabotegravir (CAB) for PrEP in Uganda.

Research, Service Delivery

Document
15 February 2023

Incorporating End-users’ Voices into the Development of an Implant for HIV Prevention: A discrete choice experiment in South Africa and Zimbabwe

This article from BMC Women’s Health describes the results of a discrete choice experiment undertaken with adolescent girls and young women in South Africa and Zimbabwe where participants were asked their preferences for a hypothetical HIV prevention implant.

Research

External Link
10 February 2023

PrEPVacc Study

The PrEPVacc trial, taking place in Mozambique, South Africa, Tanzania, and Uganda from 2018 to 2024, combines an evaluation of experimental HIV vaccines and oral PrEP at the same time. The PrEP arm of the trial compares the effectiveness of TDF/FTC (Truvada) with F/TAF (Descovy).

Research

External Link
10 February 2023

Stratégie Nationale de Création de la Demande pour la PrEP Orale au Togo 2023 – 2025

Le Programme National de Lutte contre le SIDA, les Hépatites Virales et les IST (PNLS-HV-IST) du Togo, avec le soutien du projet Ending AIDS in West Africa (#EAWA) de l’USAID, a développé ces documents stratégiques pour s’assurer que tous les intervenants au Togo partagent les mêmes objectifs, approches et messages communs pour augmenter la demande…

Demand Creation/Marketing

Document
6 February 2023

Pregnancy and Neonatal Safety Outcomes of Timing of Initiation of Daily Oral Tenofovir Disoproxil Fumarate and Emtricitabine Pre-exposure Prophylaxis for HIV Prevention (CAP016): An open-label, randomised, non-inferiority trial

This article from The Lancet HIV describes the results of a trial to compare pregnancy and neonatal outcomes in women exposed and not exposed to oral PrEP (TDF/FTC) during pregnancy in Durban, South Africa.

Research

External Link
26 January 2023

Linking PEP and PrEP Services: Job Aid for Providers

This job aid for providers in Eswatini supports linking PEP and PrEP services as elements of a comprehensive combination HIV prevention package. It includes information on understanding PEP, providing PrEP to PEP users, and algorithms for assessing PEP initiation and for assessing PrEP use in clients returning after a full course of PEP. It is…

Service Delivery

Document
23 January 2023

Nurse-facilitated PrEP Delivery for Adolescent Girls and Young Women Seeking Contraception at Retail Pharmacies in Kisumu, Kenya

This article from AIDS evaluates PrEP uptake, initiation, and continuation within a nurse-facilitated pharmacy-based delivery model for Kenyan adolescent girls and young women seeking contraception at retail pharmacies.

Research, Service Delivery

External Link
16 January 2023

Predicted Effects of the Introduction of Long-acting Injectable Cabotegravir Pre-exposure Prophylaxis in Sub-Saharan Africa: A modelling study

This article from The Lancet HIV uses modelling to project the health benefits and risks of cabotegravir for PrEP introduction in settings in sub-Saharan Africa.

Research

External Link